Clinical Trial Update: Efficacy of Rectal Infiltration of Exparel for Analgesic Benefit Following Hemorrhoidectomy [Phase 4]

View source ↗

Summary

Phase 4 trial update on rectal infiltration of Exparel (bupivacaine liposome) for analgesic benefit after hemorrhoidectomy; study terminated with posted results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhoids

Drugs mentioned

• Exparel (liposomal bupivacaine)

Snippet

Sponsor: St. Luke's-Roosevelt Hospital Center | Conditions: Hemorrhoid | Phase 4 | Status: TERMINATED | Results posted: 2018-12-04